Table 1.
Cohort 1 (n=10), (%) | Cohort 2 (n=10), (%) | |
Sex | ||
Male | 6 (60) | 6 (60) |
Female | 4 (40) | 4 (40) |
Age in years | ||
8–10 | 1 (10) | 3 (30) |
11–14 | 4 (40) | 3 (30) |
15–18 | 5 (50) | 4 (40) |
Diagnosis | ||
Leukaemia/lymphoma | 9 (90) | 4 (40) |
Solid tumour | 1 (10) | 3 (30) |
Brain tumour | 0 | 2 (20) |
Other* | 0 | 1 (10) |
Metastatic disease | 0 | 0 |
Relapse | 1 (10) | 1 (10) |
Stem cell transplantation | 1 (10) | 1 (10) |
Active treatment | 7 (70) | 4 (40) |
Born in country of interview | 6 (60) | 9 (90) |
Type of Spanish spoken | ||
Mexican | 5 (50) | 8 (80) |
Central American | 2 (20) | 0 |
South American | 1 (10) | 1 (10) |
Other | 2 (20) | 1 (10) |
Inpatient at interview | 0 | 1 (10) |
Attending school | 5 (50) | 9 (90) |
*Other—primary immunodeficiency (n=1).
SSPedi, Symptom Screening in Paediatrics Tool.